SE393381B - Analogiforfarande for framstellning av 8-azapurin - 6 - onderivat - Google Patents
Analogiforfarande for framstellning av 8-azapurin - 6 - onderivatInfo
- Publication number
- SE393381B SE393381B SE7116090A SE1609071A SE393381B SE 393381 B SE393381 B SE 393381B SE 7116090 A SE7116090 A SE 7116090A SE 1609071 A SE1609071 A SE 1609071A SE 393381 B SE393381 B SE 393381B
- Authority
- SE
- Sweden
- Prior art keywords
- underivatives
- azapurin
- preparation
- analogical procedure
- analogical
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
- C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB5955270 | 1970-12-15 | ||
GB5955670 | 1970-12-15 | ||
GB4975671A GB1338235A (en) | 1970-12-15 | 1971-10-26 | Azapurinones |
GB5345771 | 1971-11-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
SE393381B true SE393381B (sv) | 1977-05-09 |
Family
ID=27449009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7116090A SE393381B (sv) | 1970-12-15 | 1971-12-14 | Analogiforfarande for framstellning av 8-azapurin - 6 - onderivat |
Country Status (25)
Country | Link |
---|---|
US (1) | US3987160A (sv) |
JP (1) | JPS5310599B1 (sv) |
AR (4) | AR192602A1 (sv) |
AT (4) | AT317211B (sv) |
AU (1) | AU458277B2 (sv) |
BE (1) | BE776683A (sv) |
BG (3) | BG20806A3 (sv) |
CH (5) | CH550814A (sv) |
DD (1) | DD95007A5 (sv) |
DE (1) | DE2162096A1 (sv) |
DK (1) | DK141249B (sv) |
FI (1) | FI53457C (sv) |
FR (1) | FR2118078B1 (sv) |
GB (1) | GB1338235A (sv) |
HK (1) | HK42177A (sv) |
HU (1) | HU165079B (sv) |
IE (1) | IE35897B1 (sv) |
IL (1) | IL38364A (sv) |
IS (1) | IS1099B6 (sv) |
LU (1) | LU64457A1 (sv) |
NL (1) | NL174943C (sv) |
NO (1) | NO134257C (sv) |
OA (1) | OA03930A (sv) |
SE (1) | SE393381B (sv) |
ZM (1) | ZM18971A1 (sv) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1493685A (en) * | 1970-12-15 | 1977-11-30 | May & Baker Ltd | 8-azapurinones |
BE792648A (fr) * | 1971-12-13 | 1973-06-12 | May & Baker Ltd | Derives de l'isoquinoleine |
FR2406638A1 (fr) * | 1977-10-21 | 1979-05-18 | May & Baker Ltd | Nouvelles aza-8 purinones-6, leur preparation et les compositions pharmaceutiques les contenant |
EP0007727B1 (en) * | 1978-07-24 | 1983-11-30 | Beecham Group Plc | Benzopyranotriazoles, preparation of these compounds and pharmaceutical composition containing them |
JPS60226887A (ja) * | 1984-04-25 | 1985-11-12 | Dai Ichi Seiyaku Co Ltd | トリアゾロピリミジン誘導体 |
CA1303037C (en) * | 1987-02-02 | 1992-06-09 | Smith Kline & French Laboratories Limited | Purinone derivatives as bronchodilators vasodilators and anti-allergic agents |
EP0288431B1 (de) * | 1987-04-07 | 1992-08-19 | Ciba-Geigy Ag | 3H-1,2,3-Triazolo[4,5-d]pyrimidine |
US5204353A (en) * | 1987-04-07 | 1993-04-20 | Ciba-Geigy Corporation | 3-benzyl-3H-1,2,3-triazolo[4,5-d]pyrimidines, compositions thereof, and method of treating epilepsy therewith |
FR2618073B1 (fr) * | 1987-07-16 | 1990-09-07 | Pf Medicament | Comprimes de type a matrice hydrophile a base de salbutamol et leur procede de preparation |
GB8817651D0 (en) * | 1988-07-25 | 1988-09-01 | Smith Kline French Lab | Chemical compounds |
DE4211239C2 (de) * | 1992-04-03 | 1995-11-16 | Max Planck Gesellschaft | Arzneimittel gegen Herz-Kreislauf-Erkrankungen |
US5734053A (en) * | 1992-06-26 | 1998-03-31 | Pfizer Inc | Purinone antianginal agents |
GB9213623D0 (en) * | 1992-06-26 | 1992-08-12 | Pfizer Ltd | Therapeutic agents |
GB9311920D0 (en) | 1993-06-09 | 1993-07-28 | Pfizer Ltd | Therapeutic agents |
US6746691B2 (en) | 1993-09-20 | 2004-06-08 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics |
US6080428A (en) * | 1993-09-20 | 2000-06-27 | Bova; David J. | Nicotinic acid compositions for treating hyperlipidemia and related methods therefor |
US20080045573A1 (en) * | 1993-09-20 | 2008-02-21 | Bova David J | Methods and Sustained Release Nicotinic Acid Compositions for Treating Hyperlipidemia |
US6676967B1 (en) | 1993-09-20 | 2004-01-13 | Kos Pharmaceuticals, Inc. | Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia |
US6818229B1 (en) | 1993-09-20 | 2004-11-16 | Kos Pharmaceuticals, Inc. | Intermediate release nicotinic acid compositions for treating hyperlipidemia |
US6129930A (en) * | 1993-09-20 | 2000-10-10 | Bova; David J. | Methods and sustained release nicotinic acid compositions for treating hyperlipidemia at night |
GB9404485D0 (en) * | 1994-03-09 | 1994-04-20 | Cancer Res Campaign Tech | Benzamide analogues |
PT1049695E (pt) | 1997-11-12 | 2002-07-31 | Bayer Ag | Imidazotriazinonas 2-fenil substituidas enquanto inibidores de fosfodiesterase |
DE19838705A1 (de) * | 1998-08-26 | 2000-03-02 | Bayer Ag | Neue Dihydro-(1,2,3)-triazolo-[4,5-d]pyrimidin-7-one |
IT1318674B1 (it) * | 2000-08-08 | 2003-08-27 | Nicox Sa | Faramaci per l'incontinenza. |
DE10232113A1 (de) | 2002-07-16 | 2004-01-29 | Bayer Ag | Vardenafil Hydrochlorid Trihydrat enthaltende Arzneimittel |
US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
DE102005009240A1 (de) | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften |
US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
DK2170930T3 (da) | 2007-06-04 | 2012-11-05 | Synergy Pharmaceuticals Inc | Agonister af guanylatcyclase, anvendelige til behandlingen af gastrointestinale sygdomme, inflammation, cancer og andre sygdomme |
JP2011522828A (ja) | 2008-06-04 | 2011-08-04 | シナジー ファーマシューティカルズ インコーポレイテッド | 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト |
ES2624828T3 (es) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros |
US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
ES2664873T3 (es) | 2011-03-01 | 2018-04-23 | Synergy Pharmaceuticals Inc. | Proceso de preparación de agonistas de guanilato ciclasa C |
EP2958577A2 (en) | 2013-02-25 | 2015-12-30 | Synergy Pharmaceuticals Inc. | Guanylate cyclase receptor agonists for use in colonic cleansing |
US9708367B2 (en) | 2013-03-15 | 2017-07-18 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase and their uses |
AU2014235209B2 (en) | 2013-03-15 | 2018-06-14 | Bausch Health Ireland Limited | Guanylate cyclase receptor agonists combined with other drugs |
KR102272746B1 (ko) | 2013-06-05 | 2021-07-08 | 보슈 헬스 아일랜드 리미티드 | 구아닐레이트 사이클라제 c의 초순수 작용제, 및 이의 제조 및 사용 방법 |
KR20220147691A (ko) | 2013-08-09 | 2022-11-03 | 알데릭스, 인코포레이티드 | 인산염 수송을 억제하기 위한 화합물 및 방법 |
MX2019006938A (es) | 2016-12-14 | 2019-09-06 | Respira Therapeutics Inc | Metodos y composiciones para trataminto de hipertension pulmonar y otros trastornos del pulmon. |
KR20210119485A (ko) | 2019-01-24 | 2021-10-05 | 프로메테우스 바이오사이언시즈, 인크. | Gpr35 조절제 |
JP2022533251A (ja) | 2019-05-21 | 2022-07-21 | アルデリックス, インコーポレイテッド | 患者において血清リン酸塩を低下させるための組み合わせ |
CA3186635A1 (en) * | 2020-07-23 | 2022-01-27 | Robert Higuchi | Therapeutic agents targeting gpr35 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2407204A (en) * | 1944-07-22 | 1946-09-03 | American Cyanamid Co | Triazolo (d) pyrimidines and methods of preparing the same |
US2993039A (en) * | 1959-11-06 | 1961-07-18 | Upjohn Co | Preparing nu-glycosides of aldose and ketose sugars |
-
1971
- 1971-10-26 GB GB4975671A patent/GB1338235A/en not_active Expired
- 1971-12-06 DK DK596371AA patent/DK141249B/da not_active IP Right Cessation
- 1971-12-14 CH CH1853672A patent/CH550814A/fr not_active IP Right Cessation
- 1971-12-14 IS IS2047A patent/IS1099B6/is unknown
- 1971-12-14 CH CH1853872A patent/CH546779A/fr not_active IP Right Cessation
- 1971-12-14 NL NLAANVRAGE7117142,A patent/NL174943C/xx not_active IP Right Cessation
- 1971-12-14 JP JP10078571A patent/JPS5310599B1/ja active Pending
- 1971-12-14 AU AU36867/71A patent/AU458277B2/en not_active Expired
- 1971-12-14 CH CH1823271A patent/CH555351A/fr not_active IP Right Cessation
- 1971-12-14 DE DE19712162096 patent/DE2162096A1/de active Granted
- 1971-12-14 OA OA54440A patent/OA03930A/xx unknown
- 1971-12-14 FR FR7144869A patent/FR2118078B1/fr not_active Expired
- 1971-12-14 BE BE776683A patent/BE776683A/xx not_active IP Right Cessation
- 1971-12-14 DD DD159572A patent/DD95007A5/xx unknown
- 1971-12-14 IE IE1583/71A patent/IE35897B1/xx unknown
- 1971-12-14 NO NO4614/71A patent/NO134257C/no unknown
- 1971-12-14 IL IL38364A patent/IL38364A/xx unknown
- 1971-12-14 CH CH1853772A patent/CH556860A/xx not_active IP Right Cessation
- 1971-12-14 CH CH222574A patent/CH552610A/fr not_active IP Right Cessation
- 1971-12-14 SE SE7116090A patent/SE393381B/sv unknown
- 1971-12-14 HU HUMA2296A patent/HU165079B/hu unknown
- 1971-12-14 FI FI3560/71A patent/FI53457C/fi active
- 1971-12-14 ZM ZM189/71A patent/ZM18971A1/xx unknown
- 1971-12-14 LU LU64457D patent/LU64457A1/xx unknown
- 1971-12-15 BG BG20379A patent/BG20806A3/xx unknown
- 1971-12-15 BG BG19250A patent/BG20805A3/xx unknown
- 1971-12-15 AT AT272373A patent/AT317211B/de not_active IP Right Cessation
- 1971-12-15 AT AT272473A patent/AT315839B/de not_active IP Right Cessation
- 1971-12-15 AT AT272273A patent/AT319235B/de not_active IP Right Cessation
- 1971-12-15 AR AR239632A patent/AR192602A1/es active
- 1971-12-15 AT AT1075671A patent/AT315838B/de not_active IP Right Cessation
- 1971-12-15 BG BG20380A patent/BG20807A3/xx unknown
-
1972
- 1972-12-06 AR AR245510A patent/AR192689A1/es active
- 1972-12-06 AR AR245509A patent/AR199468A1/es active
- 1972-12-06 AR AR245508A patent/AR199467A1/es active
-
1973
- 1973-05-29 US US05/364,425 patent/US3987160A/en not_active Expired - Lifetime
-
1977
- 1977-08-11 HK HK421/77A patent/HK42177A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE393381B (sv) | Analogiforfarande for framstellning av 8-azapurin - 6 - onderivat | |
SE383887B (sv) | Analogiforfarande for framstellning av alfa-amino-cyklohexadienyl-alkylen-penicilliner | |
SE390304B (sv) | Analogiforfarande for framstellning av 4-hydroxi-5-etyl-6-fonylpyrimidin | |
SE394678B (sv) | Analogiforfarande for framstellning av pyridokinolinderivat | |
SE406197B (sv) | Analogiforfarande for framstellning av 4-aminokinazolinderivat | |
NO138883C (no) | Fremgangsmaate for fremstilling av oksiranforbindelser | |
SE400292B (sv) | Forfarande for framstellning av benshydryl-3-karbamoyloximetyl-7-tienylacetamido-7-metoxidecefalosporanat | |
SE399701B (sv) | Forfarande for framstellning av hydroxyalkyldiamin | |
SE394436B (sv) | Forfarande for framstellning av 7-halogen-linkomyciner | |
SE380273B (sv) | Forfarande for framstellning av tiopyrimidinderivat | |
SE385011B (sv) | Forfarande for framstellning av alfa-linkosaminider | |
SE399069B (sv) | Analogiforfarande for framstellning av triazolo-pyridino-isokinolin-derivat | |
SE395897B (sv) | Forfarande for framstellning av 7beta-acylamido-3-metyl-cef-3-em-4-karbonsyror | |
SE397090B (sv) | Forfarande for framstellning av hydroxipyrimidiner | |
SE405478B (sv) | Forfarande for framstellning av alfa-sulfoacylcefalosporiner | |
SE408418B (sv) | Forfarande for framstellning av 5-fluor-pyrimidiner | |
SE395699B (sv) | Forfarande for framstellning av kinuklidin-kinolinderivat | |
SE388611B (sv) | Analogiforfarande for framstellning av 1,4-bensodiazeponderivat | |
SE380795B (sv) | Forfarande for framstellning av tiokarbamider | |
SE411759B (sv) | Forfarande for framstellning av erytromycyliminforeningar | |
SE398114B (sv) | Analogiforfarande for framstellning av aminoetrar | |
SE380520B (sv) | Forfarande for framstellning av 1-cinnamylidenamino-3-bensylidenaminoguanidin | |
SE382046B (sv) | Forfarande for framstellning av 1-aryloxi-2-propanol | |
SE404803B (sv) | Analogiforfaranden for framstellning av pyrido-diazepiner | |
SE382051B (sv) | Forfarande for framstellning av 3-sulfonamid-4-hydroxifenyl-2-piperidylkarbinoler |